Laparoscopic sleeve gastrectomy versus laparoscopic mini-gastric bypass and early metabolic outcome in super-obese patients
DOI:
https://doi.org/10.18203/2349-2902.isj20195943Keywords:
Bariatric surgery, Dyslipidemia, Mini-gastric bypass, Sleeve gastrectomy, Type 2 diabetes mellitusAbstract
Background: Bariatric surgery became the most popular choice in the management of obesity. Laparoscopic sleeve gastrostomy (LSG) and laparoscopic mini-gastric bypass (LMGB) has taken place in weight-loss and improvement in comorbidities.
Methods: This was a retrospective cohort study with equal allocation included 112 super-obese patients with body mass index ≥50 kg/m2, which carried out in General Surgery department of Al-Azhar University Hospitals, between January 2016 and December 2018. 56 patients underwent LSG (Group A), and 56 patients underwent LMGB (Group B). Metabolic effect and weight loss outcomes were evaluated over one year.
Results: Operative time was shorter in LSG than LMGB (64.3±33.32 min versus 70±37.24 min). There was a highly significant more weight loss in LSG than in LMGB at 6 and 12 months following the surgery. Also, improvement of type 2 diabetes mellitus, hypertension, hyperlipidemia, and quality of life occurred after 1 year in both surgeries.
Conclusions: LSG and LMGB were better optimal procedures for super-obese patients with a comparable percent excess weight loss and improvement of associated comorbidities.
References
Sarwer DB, Wadden TA, Moore RH et al: Changes in quality of life and body image after gastric bypass surgery. Surg Obes Relat Dis. 2010;6:608-14.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults- the Evidence Report. National Institutes of Health. Obes Res. 1998;6 Suppl 2:51S.
Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219-34.
Fielding GA. Laparoscopic adjustable gastric banding for massive super-obesity (>60 body mass index kg/m2). Surg Endosc. 2003;17:1541-5.
Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71-82.
WHO Obesity and overweight Updated June 2016. Available at: http://www.who.int/mediacentre/ factsheets/fs311/en.
Kyrou I, Osei-Assibey G, Williams N, Thomas R, Halder L, Taheri S, et al: Self-reported disability in adults with severe obesity. J Obes. 2011;2011:918402.
Chaim EA, Pareja JC, Gestic MA. Preoperative multidisciplinary program for bariatric surgery a proposal for the Brazilian Public Health System. Arq Gastro-enterol. 2017;54(1):70-4.
Chakravarty PD, McLaughlin E, Whittaker D, Byrne E, Cowan E, Xu K, et al. Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures: a systematic review of the randomised controlled trials. Surg. 2012;10:172-82.
Benotti P, Wood GC, Winegar DA, Petrick AT, Still CD, Argyropoulos G, et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg. 2014;259:123-30.
Suter M, Calmes JM, Paroz A, Romy S, Giusti V. Results of Roux-en-Y gastric bypass in morbidly obese vs super obese patients: Similar body weight loss, correction of comorbidities, and improvement of quality of life. Arch Surg. 2009;144:312-8.
Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ. Laparoscopic bariatric surgery in super-obese patients (BMI >50) is safe and effective: A review of 332 patients. Obes Surg. 2005;15:858-63.
Kakarla VR, Nandipati K, Lalla M, Castro A, Merola S. Are laparoscopic bariatric procedures safe in superobese (BMI >50 kg/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis. 2011;7:452-8.
Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res. 1999;7(5):477-84.
Buchwald H, Estok R, Fahrbach K. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248.e5-56.e5.
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-76.
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19:1605-11.
Rutledge R. The mini-gastric bypass experience with the first 1,274 cases. Obes Surg. 2001;11(3):276-80.
Adams TD, Gress RE, Smith SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-61.
Mostafa EA, Abdelwahab EA, Abosayed YG, Gafar MH. Lararoscopic sleeve gastrectomy versus laparoscopic mini-gastric bypass in management of morbid obesity and its comorbidities. Menoufia Med. 2019;31:1181-6.
Plamper A, Lingohr P, Nadal J, Rheinwalt KP. Comparison of mini-gastric bypass with sleeve gastrectomy in a mainly super-obese patient group first results. Surg Endosc. 2017;31:1156-62.
Lee WJ, Pok EH, Almulaifi A, Tsou JJ, Ser KH, Lee C. Medium-term results of laparoscopic sleeve gastrectomy: a matched comparison with gastric bypass. Obes Surg. 2015;25(8):1431-8.
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian subcontinent. Obes Surg. 2014;24(10):1724-8.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926-32.
Sczepaniak JP, Owens ML, Shukla H, Perlegos J, Garner W. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011. Obes Surg. 2015;25:788-95.
Ramos AC, Silva AC, Ramos MG. Simplified gastric bypass 13 years of experience and 12,000 patients operated. Arq Bras Cir Dig. 2014;27(1):2-8.
Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M, et al. Early results of the swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscop-ic laparoscopic sleeve gastrectomy and roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690.
Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Kowala M, Haj FG, et al. Vertical laparoscopic sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD- T2DMrats. Endocrinol. 2012;153(8):3620-32.
Kansou G, Lechaux D, Delarue J, Badic B, LE gall M, Guillerm S, et al. laparoscopic sleeve gastrectomy versus laparoscopic mini bypass: one year outcomes. Int J Surg. 2016;33:18e22.
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-200.
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone. G. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
